Synthetic cannabinoids can cause acute adverse psychological effects, but the potential impact when exposure happens before birth is unknown. Use of synthetic cannabinoids during pregnancy may affect fetal brain development, and such effects could be moderated by the genetic makeup of an individual. Disrupted in schizophrenia 1 () is a gene with important roles in neurodevelopment that has been associated with psychiatric disorders in pedigree analyses.
View Article and Find Full Text PDF